{"id":13777,"date":"2024-09-04T11:54:30","date_gmt":"2024-09-04T11:54:30","guid":{"rendered":"https:\/\/rclawus.com\/?p=13777"},"modified":"2024-10-03T13:25:32","modified_gmt":"2024-10-03T13:25:32","slug":"rc-law-advised-insud-pharma-on-its-acquisition-of-agile-therapeutics","status":"publish","type":"post","link":"https:\/\/rclawus.com\/rc-law-advised-insud-pharma-on-its-acquisition-of-agile-therapeutics\/","title":{"rendered":"RC Law Advised Insud Pharma on its Acquisition of Agile Therapeutics"},"content":{"rendered":"<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-13970 size-medium\" src=\"https:\/\/i0.wp.com\/rclawus.com\/wp-content\/uploads\/2024\/09\/insud-pharma-800x600-1-1.png?resize=300%2C225&#038;ssl=1\" alt=\"\" width=\"300\" height=\"225\" srcset=\"https:\/\/i0.wp.com\/rclawus.com\/wp-content\/uploads\/2024\/09\/insud-pharma-800x600-1-1.png?resize=300%2C225&amp;ssl=1 300w, https:\/\/i0.wp.com\/rclawus.com\/wp-content\/uploads\/2024\/09\/insud-pharma-800x600-1-1.png?resize=768%2C576&amp;ssl=1 768w, https:\/\/i0.wp.com\/rclawus.com\/wp-content\/uploads\/2024\/09\/insud-pharma-800x600-1-1.png?resize=705%2C529&amp;ssl=1 705w, https:\/\/i0.wp.com\/rclawus.com\/wp-content\/uploads\/2024\/09\/insud-pharma-800x600-1-1.png?w=800&amp;ssl=1 800w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><a class=\"app-aware-link \" href=\"https:\/\/www.linkedin.com\/company\/rclawllp\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">RC Law LLP<\/a> is proud to have advised <a class=\"app-aware-link \" href=\"https:\/\/www.linkedin.com\/company\/insud-pharma\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">Insud Pharma<\/a> S.L., a global pharmaceutical group based in Spain, on its acquisition of <a class=\"app-aware-link \" href=\"https:\/\/www.linkedin.com\/company\/agiletherapeutics\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">Agile Therapeutics<\/a>, Inc (OTCOB, AGRX) through the merger of the target company with one of the client\u2019s US subsidiaries, as reported by <a class=\"app-aware-link \" href=\"https:\/\/www.linkedin.com\/company\/nasdaq\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">Nasdaq<\/a> on August 26, 2024. <a class=\"app-aware-link \" href=\"https:\/\/www.linkedin.com\/company\/loeb-loeb-llp\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">Loeb &amp; Loeb LLP<\/a> acted as co-counsel for Insud Pharma and the target and its shareholders were advised by <a class=\"app-aware-link \" href=\"https:\/\/www.linkedin.com\/company\/morgan-lewis-&amp;-bockius-llp\/\" target=\"_self\" rel=\"noopener\" data-test-app-aware-link=\"\">Morgan, Lewis &amp; Bockius LLP<\/a>.<\/p>\n<p>Source: https:\/\/www.nasdaq.com\/press-release\/agile-therapeutics-inc-announces-completion-acquisition-insud-pharma-sl-2024-08-26https:\/\/lnkd.in\/eQCbEBx2<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; RC Law LLP is proud to have advised Insud Pharma S.L., a global pharmaceutical group based in Spain, on its acquisition of Agile Therapeutics, Inc (OTCOB, AGRX) through the merger of the target company with one of the client\u2019s US subsidiaries, as reported by Nasdaq on August 26, 2024. Loeb &amp; Loeb LLP acted [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":14183,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[29],"tags":[27,26,24,21,20],"class_list":["post-13777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-carla-marco","tag-diego-price","tag-florencia-fernandez","tag-marta-garcia","tag-xavier-ruiz"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/rclawus.com\/wp-content\/uploads\/2024\/09\/Insud-Pharma.png?fit=800%2C600&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/posts\/13777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/comments?post=13777"}],"version-history":[{"count":5,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/posts\/13777\/revisions"}],"predecessor-version":[{"id":14185,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/posts\/13777\/revisions\/14185"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/media\/14183"}],"wp:attachment":[{"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/media?parent=13777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/categories?post=13777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rclawus.com\/wp-json\/wp\/v2\/tags?post=13777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}